INVIVO1290, formerly known as Grp94-selective Inhibitor, is a purine-based inhibitor of Grp94. Specifically, it is a Grp94-selective resorcinol-based inhibitor isolated through probing of the exclusive binding region of S2 subpocket in Grp94. INVIVO1290 has CAS#2134571-29-0, which is first reported on ACS Medicinal Chemistry Letters (2017), 8(10), 1013-1018. References: Khandelwal A, Crowley VM, Blagg BSJ. Resorcinol-Based Grp94-Selective Inhibitors. ACS Medicinal Chemistry Letters (2017), 8(10), 1013-1018.

纯度：≥98%

CAS：2134571-29-0